Clin Microbiol Infect 2021 Apr 1. Epub 2021 Apr 1.
Infectious Diseases Department, Centre Hospitalier Universitaire (CHU) Saint-Pierre - Université Libre de Bruxelles (ULB), Brussels, Belgium; Robert Koch Institute, Highly Pathogenic Viruses (ZBS 1), Centre for Biological Threats and Special Pathogens, WHO Collaborating Centre for Emerging Infections and Biological Threats, Berlin, Germany; Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium; Department of Infectious Tropical diseases and Microbiology, IRCCS Ospedale Sacro Cuore Don Calabria, Negrar, Verona, Italy; Institute for Medical Immunology, Université Libre de Bruxelles (ULB), Brussels, Belgium; Environmental Health Research Centre, Public Health School, Université Libre de Bruxelles (ULB), Brussels, Belgium.
Background: We lack the rationale on which to base the development of a yellow fever (YF) vaccination schedule for people living with HIV (PLHIV).
Objectives: Report on the current evidence regarding the seroconversion rate and the duration of humoral protection after YF vaccine, as well as the impact of revaccination in PLWHIV.
Data Sources: MEDLINE, Google Scholar, LILACS and Cochrane CENTRAL were searched. Read More